Famotidine and long QT syndrome

Ken W Lee; Steven R Kayser; Richard H Hongo; Zian H Tseng; Melvin M Scheinman

doi:10.1016/j.amjcard.2004.02.025

Famotidine and long QT syndrome

Am J Cardiol. 2004 May 15;93(10):1325-7. doi: 10.1016/j.amjcard.2004.02.025.

Authors

Ken W Lee¹, Steven R Kayser, Richard H Hongo, Zian H Tseng, Melvin M Scheinman

Affiliation

¹ Division of Cardiology, Cardiac Electrophysiology Section, University of California at San Francisco, 500 Parnassus Avenue, MU East 4, Box 1354, San Francisco, CA 94143, USA. klee@medicine.ucsf.edu

PMID: 15135720
DOI: 10.1016/j.amjcard.2004.02.025

Abstract

Numerous drugs have been implicated in causing a prolonged QT interval and Torsades de pointes. However, the association of famotidine and acquired long QT syndrome has rarely been reported. We report 2 cases of famotidine-associated acquired long QT syndrome.

Publication types

Case Reports

MeSH terms

Aged
Aged, 80 and over
Diagnosis, Differential
Electrocardiography
Famotidine / adverse effects*
Heart Failure
Histamine H2 Antagonists / adverse effects*
Humans
Long QT Syndrome / chemically induced*
Long QT Syndrome / diagnosis*
Long QT Syndrome / physiopathology
Male
Middle Aged
Myocardial Infarction

Substances

Histamine H2 Antagonists
Famotidine